[HTML][HTML] The effect of off-label use of reduced-dose direct oral anticoagulants therapy in the treatment of pulmonary embolism comparable to standard-dose therapy
S Yamazoe, H Imai, Y Ogawa, N Kano, Y Murase… - Heart and Vessels, 2024 - Springer
Direct oral anticoagulants (DOACs) have been shown to be effective and safe in preventing
pulmonary embolism recurrence. In this single-center retrospective observational study, we …
pulmonary embolism recurrence. In this single-center retrospective observational study, we …
The effect of off-label use of reduced-dose direct oral anticoagulants therapy in the treatment of pulmonary embolism comparable to standard-dose therapy.
S Yamazoe, H Imai, Y Ogawa, N Kano, Y Murase… - Heart and …, 2024 - europepmc.org
Direct oral anticoagulants (DOACs) have been shown to be effective and safe in preventing
pulmonary embolism recurrence. In this single-center retrospective observational study, we …
pulmonary embolism recurrence. In this single-center retrospective observational study, we …
The effect of off-label use of reduced-dose direct oral anticoagulants therapy in the treatment of pulmonary embolism comparable to standard-dose therapy
S Yamazoe, H Imai, Y Ogawa, N Kano… - Heart and … - pubmed.ncbi.nlm.nih.gov
Direct oral anticoagulants (DOACs) have been shown to be effective and safe in preventing
pulmonary embolism recurrence. In this single-center retrospective observational study, we …
pulmonary embolism recurrence. In this single-center retrospective observational study, we …